Salarius Pharmaceuticals Inc (SLRX) Social Stream



Salarius Pharmaceuticals Inc (SLRX): $1.49

-0.01 (-0.67%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SALARIUS PHARMACEUTICALS INC (SLRX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering SLRX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 2 $5 $5 $5 $1.5 233.33%
2022-03-14 2 $5 $4 $4.5 $1.5 200%
2022-11-14 1 $125 $125 $125 $1.5 8233.33%
2023-04-06 1 $5 $5 $5 $1.5 233.33%
2023-05-17 1 $17 $5 $11 $1.5 633.33%

Price Target Last Issued May 17, 2023

The Trend in the Analyst Price Target


Over the past 40 weeks, SLRX's average price target has gone down $119.12.

SLRX reports an average of 7,812.94% for its upside potential over the past 40 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-11 1 5 5 5 0.241 1974.69%
2022-08-11 1 125 125 125 0.241 51767.22%
2022-11-14 1 125 125 125 1.940 6343.3%
2023-04-06 1 5 5 5 1.450 244.83%
2023-05-11 1 17 5 11 1.400 685.71%

SLRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 39 weeks, SLRX's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how SALARIUS PHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 6.46% of that group.
  • In terms of how SALARIUS PHARMACEUTICALS INC fares relative to all US stocks, note that its average analyst price target is higher than 108.14% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, SALARIUS PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1.65% of them.
  • In terms of how SALARIUS PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 456.27% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to SALARIUS PHARMACEUTICALS INC are ALDX, AMPH, and IMUX.

Make investment decisions regarding SLRX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6893 seconds.